MRCP Part 1 → Dermatology
Dermatology accounts for roughly 4% of the MRCP Part 1 blueprint. This bank has 179 items tagged to it.
Around 4% of the paper, per MRCP(UK) examination blueprints and regulations. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 30-year-old man has well-demarcated red plaques with silvery scale over both elbows, knees and his scalp. His fingernails show pitting and separation of the nail from the bed. The plaques are only mildly itchy. What is the most likely diagnosis?
The point: Psoriasis is a common, long-term skin disease caused by the immune system, driven by a type of immune cell called a T-cell switching on and skin cells (keratinocytes) being made and shed too fast. The commonest type, chronic plaque psoriasis, causes well-defined red patches (plaques) with silvery scale over the elbows, knees, scalp and behind the ears, with nail changes such as pitting and the nail lifting away from the bed (onycholysis). Other patterns are guttate psoriasis (small drop-like spots after a strep throat infection), flexural (inverse) psoriasis in the skin folds, pustular psoriasis, and the rare emergency of erythrodermic psoriasis, where almost the whole skin is affected. Up to a third of patients develop psoriatic arthritis, so joints should be checked, and there is a link with metabolic syndrome (a cluster of conditions including high blood pressure and high blood sugar) and heart disease risk. Triggers include strep infection, stress, injury to the skin (the Koebner phenomenon, where new patches appear along a scratch or scar), and drugs such as beta-blockers, lithium and antimalarials, with a flare-up if steroid tablets are stopped suddenly. First-choice treatment of plaque disease is a cream or ointment: a strong steroid cream plus a vitamin D cream such as calcipotriol. When creams are not enough, light treatment (phototherapy) and then drugs that work throughout the body (methotrexate, ciclosporin, acitretin) or biologic drugs are used under a specialist. It is a lifelong condition that flares up and settles down, managed to control it rather than cure it, with attention to the joint and heart risks that go with it.
Source: NICE CG153 — psoriasis: assessment and management NICE · tier 1, national regulator or guidance
A 30-year-old man has well-demarcated red plaques with silvery scale over both elbows, knees and his scalp. His fingernails show pitting and separation of the nail from the bed. The plaques are only mildly itchy. What is the most appropriate investigation?
The point: Psoriasis is a common, long-term skin disease caused by the immune system, driven by a type of immune cell called a T-cell switching on and skin cells (keratinocytes) being made and shed too fast. The commonest type, chronic plaque psoriasis, causes well-defined red patches (plaques) with silvery scale over the elbows, knees, scalp and behind the ears, with nail changes such as pitting and the nail lifting away from the bed (onycholysis). Other patterns are guttate psoriasis (small drop-like spots after a strep throat infection), flexural (inverse) psoriasis in the skin folds, pustular psoriasis, and the rare emergency of erythrodermic psoriasis, where almost the whole skin is affected. Up to a third of patients develop psoriatic arthritis, so joints should be checked, and there is a link with metabolic syndrome (a cluster of conditions including high blood pressure and high blood sugar) and heart disease risk. Triggers include strep infection, stress, injury to the skin (the Koebner phenomenon, where new patches appear along a scratch or scar), and drugs such as beta-blockers, lithium and antimalarials, with a flare-up if steroid tablets are stopped suddenly. First-choice treatment of plaque disease is a cream or ointment: a strong steroid cream plus a vitamin D cream such as calcipotriol. When creams are not enough, light treatment (phototherapy) and then drugs that work throughout the body (methotrexate, ciclosporin, acitretin) or biologic drugs are used under a specialist. It is a lifelong condition that flares up and settles down, managed to control it rather than cure it, with attention to the joint and heart risks that go with it.
Source: NICE CG153 — psoriasis: assessment and management NICE · tier 1, national regulator or guidance
A 30-year-old man has well-demarcated red plaques with silvery scale over both elbows, knees and his scalp. His fingernails show pitting and separation of the nail from the bed. The plaques are only mildly itchy. What is the most appropriate management?
The point: Psoriasis is a common, long-term skin disease caused by the immune system, driven by a type of immune cell called a T-cell switching on and skin cells (keratinocytes) being made and shed too fast. The commonest type, chronic plaque psoriasis, causes well-defined red patches (plaques) with silvery scale over the elbows, knees, scalp and behind the ears, with nail changes such as pitting and the nail lifting away from the bed (onycholysis). Other patterns are guttate psoriasis (small drop-like spots after a strep throat infection), flexural (inverse) psoriasis in the skin folds, pustular psoriasis, and the rare emergency of erythrodermic psoriasis, where almost the whole skin is affected. Up to a third of patients develop psoriatic arthritis, so joints should be checked, and there is a link with metabolic syndrome (a cluster of conditions including high blood pressure and high blood sugar) and heart disease risk. Triggers include strep infection, stress, injury to the skin (the Koebner phenomenon, where new patches appear along a scratch or scar), and drugs such as beta-blockers, lithium and antimalarials, with a flare-up if steroid tablets are stopped suddenly. First-choice treatment of plaque disease is a cream or ointment: a strong steroid cream plus a vitamin D cream such as calcipotriol. When creams are not enough, light treatment (phototherapy) and then drugs that work throughout the body (methotrexate, ciclosporin, acitretin) or biologic drugs are used under a specialist. It is a lifelong condition that flares up and settles down, managed to control it rather than cure it, with attention to the joint and heart risks that go with it.
Source: NICE CG153 — psoriasis: assessment and management NICE · tier 1, national regulator or guidance
Clinical sciences · Clinical pharmacology and therapeutics · Cardiology · Respiratory medicine · Gastroenterology and hepatology · Neurology · Endocrinology, diabetes and metabolic medicine · Renal medicine · Infectious diseases · Rheumatology · Haematology · Psychiatry · Geriatric medicine · Oncology · Medical ophthalmology · Palliative medicine and end of life care